TapewireFind a company

person · Reporting owner

Oelschlager Kristen M

Disclosed activity across 1 company

Tapewire entity
1624
SEC CIK
0001856565

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CASTLE BIOSCIENCES INCCSTL · Entity 359Chief Operating OfficerOctober 01, 2026October 05, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CASTLE BIOSCIENCES INC

Report date October 01, 2026 · Filed October 05, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect13,356 Ending reported balance After 2026-10-01 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2026-10-01 · Exercise / conversion · Acquired 4,153 · Balance 17,509

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

Row 2 · 2026-10-01 · Sale · Disposed 2,807 · Balance 14,702

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F2: This transaction was executed in multiple trades at prices ranging from $35.21 to $36.19, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Row 3 · 2026-10-01 · Sale · Disposed 1,346 · Balance 13,356

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F3: This transaction was executed in multiple trades at prices ranging from $36.21 to $36.78, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.38 · Expires 2029-03-12Direct8,305 Reported balance After 2026-10-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-10-01 · Exercise / conversion · Disposed 4,153 · Balance 8,305

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F5: The shares subject to the option are fully vested.

Common StockSEC Table I · non-derivativeIndirectThe Fritz Shorter Trust72,649 Reported balance Holding disclosure · report date 2026-10-01 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 72,649

F4: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.

Filing footnotes · ownership attribution and instrument terms

F1: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F2: This transaction was executed in multiple trades at prices ranging from $35.21 to $36.19, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $36.21 to $36.78, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.

F5: The shares subject to the option are fully vested.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 5, 2026 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 4,153 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0001628280-26-064912 · wk-form4_1791230843.xml · derivative · entry 5

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,305

Underlying: Common Stock · 4,153 shares

Expires 2029-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F5 · derivative.exercise_date: The shares subject to the option are fully vested.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 1,346 $36.38 $48,967.48
Disclosure

SEC source: 0001628280-26-064912 · wk-form4_1791230843.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,356

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $36.21 to $36.78, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 2,807 $35.75 $100,350.25
Disclosure

SEC source: 0001628280-26-064912 · wk-form4_1791230843.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,702

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.21 to $36.19, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 01, 2026 Filed Oct 5, 2026 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 4,153 $3.38 $14,037.14
Disclosure

SEC source: 0001628280-26-064912 · wk-form4_1791230843.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 4,152 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0001628280-26-060430 · wk-form4_1788466051.xml · derivative · entry 5

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,458

Underlying: Common Stock · 4,152 shares

Expires 2029-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F5 · derivative.exercise_date: The shares subject to the option are fully vested.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 200 $34.02 $6,804.00
Disclosure

SEC source: 0001628280-26-060430 · wk-form4_1788466051.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,356

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 3,952 $33.36 $131,838.72
Disclosure

SEC source: 0001628280-26-060430 · wk-form4_1788466051.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,556

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $33.015 to $33.900, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 4,152 $3.38 $14,033.76
Disclosure

SEC source: 0001628280-26-060430 · wk-form4_1788466051.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,508

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F2 · balance_after: Includes 68 shares acquired on August 31, 2026, under the Issuer's employee stock purchase plan.

Read SEC document
August 25, 2026 Filed Aug 26, 2026 20:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 5,223 $34.64 $180,919.50
Disclosure

SEC source: 0001628280-26-059091 · wk-form4_1787775408.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · The Fritz Shorter Trust

Disclosed balance after: 72,649

F4 · price: This transaction was executed in multiple trades at prices ranging from $34.495 to $34.750, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.

Read SEC document
August 25, 2026 Filed Aug 26, 2026 20:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 7,161 $34.26 $245,357.34
Disclosure

SEC source: 0001628280-26-059091 · wk-form4_1787775408.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · The Fritz Shorter Trust

Disclosed balance after: 77,872

F3 · price: This transaction was executed in multiple trades at prices ranging from $33.470 to $34.460, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.

Read SEC document
August 24, 2026 Filed Aug 26, 2026 20:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 12,218 $33.69 $411,587.77
Disclosure

SEC source: 0001628280-26-059091 · wk-form4_1787775408.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · The Fritz Shorter Trust

Disclosed balance after: 85,033

F1 · price: This transaction was executed in multiple trades at prices ranging from $33.500 to $33.885, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · ownership.nature: Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 1,100 $30.62 $33,682.00
Disclosure

SEC source: 0001628280-26-053391 · wk-form4_1785961098.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,288

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F4 · price: This transaction was executed in multiple trades at prices ranging from $30.55 to $30.71, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 4,486 $30.00 $134,580.00
Disclosure

SEC source: 0001628280-26-053391 · wk-form4_1785961098.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,388

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $29.53 to $30.44, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:18 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 3,000 $29.12 $87,360.00
Disclosure

SEC source: 0001628280-26-053391 · wk-form4_1785961098.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,874

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $28.46 to $29.45, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 01, 2026 Filed Jul 6, 2026 20:24 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 400 $24.78 $9,912.00
Disclosure

SEC source: 0001628280-26-047286 · wk-form4_1783369493.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,874

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F3 · price: This transaction was executed in multiple trades at prices ranging from $24.77 to $24.79, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 01, 2026 Filed Jul 6, 2026 20:24 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 8,186 $24.40 $199,738.40
Disclosure

SEC source: 0001628280-26-047286 · wk-form4_1783369493.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,274

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $23.73 to $24.72, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:19 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 8,587 $20.71 $177,836.77
Disclosure

SEC source: 0001628280-26-044327 · wk-form4_1781813983.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,460

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.51 to $20.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 11,960 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · derivative · entry 7

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,878

Underlying: Common Stock · 11,960 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F7 · derivative.exercise_date: On March 4, 2025, the Reporting Person was granted 47,838 RSUs which vest in four equal installments beginning on March 4, 2026.

F7 · derivative.expiration_date: On March 4, 2025, the Reporting Person was granted 47,838 RSUs which vest in four equal installments beginning on March 4, 2026.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 13,811 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · derivative · entry 6

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,621

Underlying: Common Stock · 13,811 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F6 · derivative.exercise_date: On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025.

F6 · derivative.expiration_date: On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025.

Read SEC document
March 04, 2026 Filed Mar 5, 2026 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 6,792 $28.17 $191,330.64
Disclosure

SEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,047

Read SEC document
March 04, 2026 Filed Mar 5, 2026 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 25,771 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 48,367 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · derivative · entry 5

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,367

Underlying: Common Stock · 48,367 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 03, 2027.

F5 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 03, 2027.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 2,427 $27.57 $66,912.39
Disclosure

SEC source: 0001628280-26-015352 · wk-form4_1772749013.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,068

F1 · shares: Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the delivery of vested performance stock units reported on January 12, 2026.

F2 · balance_after: Includes 965 shares acquired on February 27, 2026, under the Issuer's employee stock purchase plan.

Read SEC document
January 12, 2026 Filed Jan 14, 2026 21:30 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantPerformance-Based Stock Unit · Derivative 9,207 $0.00 $0.00
Disclosure

SEC source: 0001856565-26-000002 · form4-01142026_040106.xml · derivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,207

Underlying: Common Stock · 9,207 shares

Expires not disclosed

F3 · derivative.exercise_price: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2024 PSUs which will vest subject to the achievement of certain milestones.

F3 · derivative.exercise_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2024 PSUs which will vest subject to the achievement of certain milestones.

F3 · derivative.expiration_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2024 PSUs which will vest subject to the achievement of certain milestones.

Read SEC document
January 12, 2026 Filed Jan 14, 2026 21:30 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantCommon Stock 9,207 $0.00 $0.00
Disclosure

SEC source: 0001856565-26-000002 · form4-01142026_040106.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,530

F1 · shares: Represents 50% of the Performance-Based Stock Units ("PSUs") granted on March 4, 2024 ("2024 PSUs") that vested based on the satisfaction of certain performance criteria as certified by the board of directors of the Issuer on January 12, 2026.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 21:06 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 14,888 $39.31 $585,291.94
Disclosure

SEC source: 0001628280-25-058246 · wk-form4_1766178376.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,323

F1 · price: This transaction was executed in multiple trades at prices ranging from $39.055 to 39.830, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:47 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 6,170 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · derivative · entry 7

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,170 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022.

F4 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022.

Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:47 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 2,552 $38.02 $97,027.04
Disclosure

SEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · nonDerivative · entry 4

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,211

Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:47 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 6,170 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 23:47 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 15,961 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · derivative · entry 6

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,961

Underlying: Common Stock · 15,961 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023.

F3 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023.

Read SEC document
December 09, 2025 Filed Dec 11, 2025 23:47 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 4,691 $38.25 $179,430.75
Disclosure

SEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,593

Read SEC document
December 09, 2025 Filed Dec 11, 2025 23:47 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 15,961 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-25-056629 · wk-form4_1765496857.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,284

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 18,932 $35.10 $664,513.20
Disclosure

SEC source: 0001628280-25-052013 · wk-form4_1763068055.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,323

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 6, 2025

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.37, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: On November 11, 2025, the Reporting Person transferred 3,686 shares from the Fritz Shorter Trust to their direct holdings.

Read SEC document
October 31, 2025 Filed Nov 5, 2025 01:56 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 12,678 $25.04 $317,457.12
Disclosure

SEC source: 0001628280-25-049189 · wk-form4_1762307784.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,569

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 6, 2025

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to 25.12, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 27, 2025 Filed Aug 29, 2025 20:04 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 12,677 $22.02 $279,134.86
Disclosure

SEC source: 0001856565-25-000007 · wk-form4_1756497883.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,116

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 6, 2025

F2 · price: This transaction was executed in multiple trades at prices ranging from $22.000 to 22.145, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 27, 2025 Filed Aug 29, 2025 20:04 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 18,007 $21.69 $390,571.83
Disclosure

SEC source: 0001856565-25-000006 · wk-form4_1756497844.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,793

F1 · price: This transaction was executed in multiple trades at prices ranging from $21.24 to $21.94, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 27, 2025 Filed Nov 5, 2025 01:38 UTC Amendment CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 18,007 $21.69 $390,571.83
Disclosure

SEC source: 0001628280-25-049176 · wk-form4a_1762306678.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · The Fritz Shorter Trust

Disclosed balance after: 100,937

F1 · price: This transaction was executed in multiple trades at prices ranging from $21.24 to $21.94, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: On August 29, 2025, the Reporting Person filed a Form 4 which inadvertently reported that shares were sold by the Reporting Person directly. In fact, as reported in this amendment, the shares were sold by the Fritz Shorter Trust (the "Trust"). The original Form 4 also mistakenly indicated the wrong number of shares held by the Reporting Person directly and indirectly through the Trust. In fact, following this sale, the Reporting Person held 52,924 shares of common stock directly and 100,937 shares of common stock indirectly through the Trust. In addition, following a reconciliation of the reporting person's holdings, it was determined that the balance previously reported was understated by 68 shares, and the holdings reported herein have been adjusted accordingly.

F3 · ownership.nature: On March 19, 2025 and on August 22, 2025, the Reporting Person transferred 96,322 and 22,622 shares to the Trust. The transfer was not a change in beneficial ownership because the Reporting Person and her spouse are the trustees and sole beneficiaries of the Trust, the Trust is revocable and the Reporting Person has voting and investment power over the shares held by the Trust.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 20:31 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionPerformance-Based Stock Unit · Derivative 10,640 $0.00 $0.00
Disclosure

SEC source: 0001856565-25-000003 · wk-form4_1755030668.xml · derivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,640 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024.

F1 · derivative.exercise_date: Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024.

F1 · derivative.expiration_date: Each Performance-Based Stock Unit ("PSU") represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the PSUs granted on December 23, 2022, which were all subject to time-based vesting and vested in full on the one-year anniversary of August 9, 2024.

Read SEC document
August 08, 2025 Filed Aug 12, 2025 20:31 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 2,804 $19.36 $54,285.44
Disclosure

SEC source: 0001856565-25-000003 · wk-form4_1755030668.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,800

Read SEC document
August 08, 2025 Filed Aug 12, 2025 20:31 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 10,640 $0.00 $0.00
Disclosure

SEC source: 0001856565-25-000003 · wk-form4_1755030668.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,604

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 21:19 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 13,811 $0.00 $0.00
Disclosure

SEC source: 0001447362-25-000040 · wk-form4_1741295952.xml · derivative · entry 4

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,432

Underlying: Common Stock · 13,811 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025.

F4 · derivative.expiration_date: On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 21:19 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 47,838 $0.00 $0.00
Disclosure

SEC source: 0001447362-25-000040 · wk-form4_1741295952.xml · derivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,838

Underlying: Common Stock · 47,838 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2026.

F3 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2026.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 21:19 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 3,640 $22.23 $80,917.20
Disclosure

SEC source: 0001447362-25-000040 · wk-form4_1741295952.xml · nonDerivative · entry 2

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,964

Read SEC document
March 04, 2025 Filed Mar 6, 2025 21:19 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 13,811 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-25-000040 · wk-form4_1741295952.xml · nonDerivative · entry 1

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,604

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · balance_after: Includes 1,271 shares acquired on February 28, 2025, under the Issuer's employee stock purchase plan.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:49 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 6,169 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · derivative · entry 9

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,170

Underlying: Common Stock · 6,169 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022.

F5 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:49 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 1,750 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · derivative · entry 8

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs which vest in four equal installments beginning on December 10, 2021.

F4 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs which vest in four equal installments beginning on December 10, 2021.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:49 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 1,626 $29.63 $48,178.38
Disclosure

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 6

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,522

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:49 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 6,169 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 5

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,148

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:49 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 530 $29.63 $15,703.90
Disclosure

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 4

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,979

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:49 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 1,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-24-000194 · wk-form4_1733953789.xml · nonDerivative · entry 3

Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,509

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.